Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Laser Density for Actinic Keratosis
Status:
Completed
Trial end date:
2018-10-24
Target enrollment:
Participant gender:
Summary
Erbium:yttrium aluminum garnet (Er:YAG) ablative fractional laser-assisted photodynamic
therapy (AFL-PDT) has shown significant benefit for the treatment of actinic keratosis(AK).
Er:YAG ablative fractional laser ablates the epidermis and dermis without significant thermal
injury, creating microscopic ablation zones (MAZ) in the portion of the skin that the laser
is applied to. The formed MAZ depends on the laser parameters such as laser depth, laser
density and laser passes, which affect the treatment outcome.
Phase:
Phase 4
Details
Lead Sponsor:
Dong-A University
Treatments:
Anesthetics EMLA Lidocaine Lidocaine, Prilocaine Drug Combination Prilocaine Protoporphyrin IX